Novel strategies of hypertension management in chronic kidney disease

J Rysz, M Banach, B Franczyk… - Archives of Medical …, 2021 - publicum.umed.lodz.pl
Hypertension is the most frequent comorbidity affecting patients with chronic kidney disease.
It causes functional and structural changes in the kidney. According to the results of the …

Which antihypertensive drugs are the most nephroprotective and why?

P Cravedi, P Ruggenenti, G Remuzzi - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Hypertension is a major independent risk factor for kidney disease
and for faster renal function loss. Choice of antihypertensive strategies with highest …

[HTML][HTML] Application of angiotensin receptor–neprilysin inhibitor in chronic kidney disease patients: Chinese expert consensus

L Gan, X Lyu, X Yang, Z Zhao, Y Tang, Y Chen… - Frontiers in …, 2022 - frontiersin.org
Chronic kidney disease (CKD) is a global public health problem, and cardiovascular
disease is the most common cause of death in patients with CKD. The incidence and …

New therapeutic options in renal diseases--hypotensive therapy

Z Gaciong - Polskie Archiwum Medycyny Wewnetrznej, 2004 - europepmc.org
Progression of a variety of chronic renal diseases may be largely due to secondary
hemodynamic and metabolic factors, rather than the activity of the underlying disorder …

[HTML][HTML] Hypertension and chronic kidney diseases

V Monhart - Cor et Vasa, 2013 - Elsevier
Chronic kidney diseases–arising from inborn or acquired renal disorders–are one of the
most common causes of secondary hypertension. Renal parenchymatous hypertension …

Overview of hypertension in acute and chronic kidney disease

JFE Mann - Dostupno na: s www. uptodate. com.(15.1. 2016.), 2014 - uptodate.com
Hypertension is a frequent finding in both acute and chronic kidney disease, particularly with
glomerular or vascular disorders [1]. The pathogenesis and preferred treatment of …

Current problems in hypertension and nephrology

M Banach, J Rysz - Expert Opinion on Pharmacotherapy, 2010 - Taylor & Francis
The aim of this issue of Expert Opinion on Pharmacotherapy is to present the most important
and controversial problems in hypertension and nephrology. To this end, the most important …

Therapy of hypertension in kidney diseases

P Ferrari, O Bonny - Praxis, 2003 - europepmc.org
The number of patients requiring chronic renal replacement therapy due to hypertension
and diabetic nephropathy has increased steadily over the past decade in Switzerland. The …

Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug

G Gervasini, NR Robles - Expert Opinion on Investigational Drugs, 2017 - Taylor & Francis
Introduction: Patients with renal dysfunction are at a higher risk of cardiovascular disease
(CVD), which often shares manifestations with heart failure (HF). Last year, the FDA …

[HTML][HTML] New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy

A Damianaki, E Polychronopoulou, G Wuerzner… - High Blood Pressure & …, 2022 - Springer
With chronic kidney disease (CKD) being a global arising health problem, strategies for
delaying kidney disease progression and reducing the high cardiovascular risk inherent to …